tDCS + Speech-Language Therapy for Aphasia
(AphasiatDCS Trial)
Trial Summary
What is the purpose of this trial?
This trial uses a non-invasive brain stimulation technique combined with speech therapy to help stroke patients with Aphasia improve their communication skills. The brain stimulation aims to enhance the effects of language therapy by making the brain's language areas work better together. This technique has shown promise in improving language recovery in post-stroke aphasia.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
What data supports the effectiveness of the treatment tDCS + Speech-Language Therapy for Aphasia?
Research shows that combining transcranial direct current stimulation (tDCS) with speech-language therapy can improve language abilities in stroke survivors with aphasia. Studies found that active tDCS led to greater language gains compared to a placebo, and cathodal tDCS significantly improved naming accuracy in patients.12345
Is tDCS safe for use in humans, particularly for those with aphasia?
How does the tDCS + Speech-Language Therapy treatment for aphasia differ from other treatments?
This treatment combines transcranial direct current stimulation (tDCS), which uses a mild electrical current to stimulate the brain, with speech-language therapy to enhance language recovery in stroke survivors with aphasia. Unlike standard speech therapy alone, this approach may lead to greater improvements in language function by targeting specific brain areas and increasing cortical activity.13459
Research Team
Jessica Richardson, Ph.D.
Principal Investigator
University of New Mexico
Eligibility Criteria
This trial is for individuals aged 25-85 who are more than a year post-stroke and have aphasia, which affects their language abilities. They must show left-hemisphere brain damage and be responsive to naming tasks. People with other neurological diseases, right hemisphere damage, mood disorders, recent substance abuse, electrical implants that interfere with tDCS or MRI scans, medical instability or pregnancy cannot participate.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo 15 sessions of tDCS combined with speech-language training on consecutive weekdays
Assessment
Participants have 4 assessment sessions: 2 pretreatment, 1 immediately post-treatment, and 1 at 3 months follow-up
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- Targeted TDCS (Transcranial Direct Current Stimulation (tDCS))
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of New Mexico
Lead Sponsor
National Institute on Deafness and Other Communication Disorders (NIDCD)
Collaborator
National Institutes of Health (NIH)
Collaborator
National Institute of General Medical Sciences (NIGMS)
Collaborator